Blind | 6 wk | 12 wk | 18 wk | 24 wk or endpoint | Â |
---|---|---|---|---|---|
Interviewer | Â | Â | Â | Â | Â |
HAM-D-17 | X | X | X | X | Â |
CGI-S, CGI-I (subject and interviewer rated) | X | X | X | X | Â |
Q-LES-Q | X | X | X | X | Â |
Adherence, PCP Treatment* | X | X | X | X | Â |
Adherence, Medication* | X | X | X | X | Â |
Adverse Events* | X | X | X | X | Â |